Amid Johnson & Johnson's legal battles the worst case is already priced into the stock and it's now a buy, according to Bernstein.
Bernstein upgrades J&J, says valuation is 'historically cheap'
More in Pro
Here are the biggest analyst calls of the day: Apple, Netflix, Monster, Eli Lilly & more
Barclays raises Apple's price target, says the lower pricing for iPhone is working
Here's what every major analyst is saying about Netflix's earnings report
Here are the biggest analyst calls of the day: Amazon, T-Mobile, Beyond Meat, Dish & more
Low mortgage rates are giving Lowe's a boost, Piper Jaffray says in upgrading the stock
Data also provided by 